US Patent Number
9402875
Publication Date
8-2-2016
Abstract
The present invention relates to the use of novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or “Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)”), for treating brain diseases and injuries that result in dopaminergic deficiencies and mitochodrial dysfunction, e.g., reduced complex I enzyme activity.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
13/586,617
Filing Date
08/15/2012
Recommended Citation
Bradley, Luke H.; Gash, Don M.; and Gerhardt, Greg A., "Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity" (2016). Neuroscience Faculty Patents. 9.
https://uknowledge.uky.edu/neurobio_patents/9
